SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-012839
Filing Date
2017-11-13
Accepted
2017-11-13 11:45:54
Documents
27
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT form10-q.htm 10-Q 171494
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 11156
3 EXHIBIT 32.1 ex32-1.htm EX-32.1 4555
  Complete submission text file 0001493152-17-012839.txt   633484

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lcom-20170930.xml EX-101.INS 32986
5 XBRL SCHEMA FILE lcom-20170930.xsd EX-101.SCH 8336
6 XBRL CALCULATION FILE lcom-20170930_cal.xml EX-101.CAL 17385
7 XBRL DEFINITION FILE lcom-20170930_def.xml EX-101.DEF 14376
8 XBRL LABEL FILE lcom-20170930_lab.xml EX-101.LAB 62173
9 XBRL PRESENTATION FILE lcom-20170930_pre.xml EX-101.PRE 48210
Mailing Address 11767 KATY FREEWAY, SUITE 830 HOUSTON TX 77079
Business Address 11767 KATY FREEWAY, SUITE 830 HOUSTON TX 77079 (281) 668-2666
Luckycom Pharmaceuticals Inc. (Filer) CIK: 0001567098 (see all company filings)

IRS No.: 461660653 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 333-187874 | Film No.: 171194405
SIC: 2834 Pharmaceutical Preparations